Teemu T Junttila

Author PubWeight™ 9.70^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells.	Clin Cancer Res	2006	1.85
2	ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease.	Clin Cancer Res	2002	1.58
3	Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth.	Mol Biol Cell	2005	1.53
4	Angiopoietin-regulated recruitment of vascular smooth muscle cells by endothelial-derived heparin binding EGF-like growth factor.	FASEB J	2003	1.38
5	DNA topoisomerase I is a cofactor for c-Jun in the regulation of epidermal growth factor receptor expression and cancer cell proliferation.	Mol Cell Biol	2005	0.95
6	Intra- and extracellular signaling by endothelial neuregulin-1.	Exp Cell Res	2007	0.92
7	ErbB4 is downregulated in renal cell carcinoma--a quantitative RT-PCR and immunohistochemical analysis of the epidermal growth factor receptor family.	Acta Oncol	2004	0.88
8	CYT-1 isoform of ErbB4 is an independent prognostic factor in serous ovarian cancer and selectively promotes ovarian cancer cell growth in vitro.	Gynecol Oncol	2013	0.86